Krystal Biotech Inc (KRYS)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 293,354 247,796 172,511 103,808 58,154 10,946 2,390 809 0 0 0 0 0 0 0 0 0 0 0 542
Total assets US$ in thousands 1,055,840 982,318 917,658 853,296 818,355 790,350 684,026 531,847 558,450 576,379 601,324 616,874 626,295 451,095 443,556 443,018 310,844 311,451 318,145 205,131
Total asset turnover 0.28 0.25 0.19 0.12 0.07 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $293,354K ÷ $1,055,840K
= 0.28

Krystal Biotech Inc's total asset turnover ratio has shown an increasing trend over the years, starting at 0.01 in September 30, 2023, and gradually rising to 0.28 by the end of December 31, 2024. This indicates that the company's ability to generate sales from its assets has improved significantly over the period. A higher total asset turnover ratio generally signifies more efficient asset utilization, as the company is generating more revenue per dollar of assets. This improvement in turnover ratio could imply better operational efficiency and effective management of assets by Krystal Biotech Inc.